Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects

Ioana Berindan-Neagoe1 Department of Functional Genomics and Experimental Pathology, Cancer Institute, “Ion Chiricuta”, Cluj-Napoca, Romania;2 Department of Immunology, University of Medicine and Pharmacy, “I. Hatieganu”, Cluj-Napoca, Romania

Cornelia Braicu1 Department of Functional Genomics and Experimental Pathology, Cancer Institute, “Ion Chiricuta”, Cluj-Napoca, RomaniaCorrespondence[email protected]

Alexandru Irimie3 Department of Surgical Oncology, University of Medicine and Pharmacy, “I. Hatieganu”, Cluj-Napoca, Romania;4 Department of Surgery, Cancer Institute, “Ion Chiricuta”, Cluj-Napoca, Romania

Pages 6035-6047 | Published online: 12 Dec 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TeitenMHEifesSDicatoMDiederichMCurcumin – the paradigm of a multi-target natural compound with applications in cancer prevention and treatmentToxins (Basel)20102112816222069551
PubMed Web of Science ®Google Scholar
TachibanaHMolecular basis for cancer chemoprevention by green tea polyphenolEGCG Forum Nutr200961156169
PubMed Web of Science ®Google Scholar
ChedeaVBraicuCSocaciuCAntioxidant/prooxidant activity of a polyphenolic grape seed extractFood Chem20101211132139
Web of Science ®Google Scholar
NakazatoTItoKIkedaYKizakiMGreen tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen speciesClin Cancer Res200511166040604916115949
PubMed Web of Science ®Google Scholar
KanadzuMYuquanLMorimotoKDual function of (−)-epigallocatechin gallate (EGCG) in healthy human lymphocytesCancer Lett2006241225025516303244
PubMed Web of Science ®Google Scholar
KhanNAfaqFSaleemMAhmadNMukhtarHTargeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallateCancer Res20066652500250516510563
PubMed Web of Science ®Google Scholar
JinekMDoudnaJAA three-dimensional view of the molecular machinery of RNA interferenceNature2009457722840541219158786
PubMed Web of Science ®Google Scholar
TudoranOSoritauOBalacescuOEarly transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumor cellsJ Cel Mol Med2012163520530
PubMed Web of Science ®Google Scholar
CastanottoDRossiJThe promises and pitfalls of RNA-interference-based therapeuticsNature2009457722842643319158789
PubMed Web of Science ®Google Scholar
FireAZMelloCC2006The Nobel Prize in Physiology or Medicine 2006, “for their discovery of RNA interference-gene silencing by double-stranded RNA” Available from: http://www.nobelprize.org/nobel_prizes/medicine/laureates/2006/Accessed July 15, 2012
Google Scholar
StorvoldGLAndersenTIPerouCMFrengenEsiRNA: a potential tool for future breast cancer therapy?Crit Rev Oncog2006121–212715017078209
PubMedGoogle Scholar
SigalARotterVOncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genomeCancer Res200060246788679311156366
PubMed Web of Science ®Google Scholar
ZhangDAl-HendyMRichard-DavisGMontgomery-RiceVRajaratnamVAl-HendyAAntiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cellsFertil Steril20109451887189319819432
PubMed Web of Science ®Google Scholar
WeinrebOMandelSYoudimMcDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cellsFASEB J200317893593712626434
PubMed Web of Science ®Google Scholar
QinJXieLPZhengXYA component of green tea, (−)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteinsBiochem Biophys Res Commun2007354485285717266926
PubMed Web of Science ®Google Scholar
AhmedSGreen tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promiseArthritis Res Ther201012220820447316
PubMed Web of Science ®Google Scholar
GoldenEBLamPYKardoshAGreen tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitorsBlood2009113235927593719190249
PubMed Web of Science ®Google Scholar
GascoMShamiSCrookTThe p53 pathway in breast cancerBreast Cancer Res200242707611879567
PubMed Web of Science ®Google Scholar
LacroixMToilloRALeclercqGp53 and breast cancer, an updateEndocr Relat Cancer200613229332516728565
PubMed Web of Science ®Google Scholar
WangMWindgassenDPapoutsakisEA global transcriptional view of apoptosis in human T-cell activationBMC Med Genomics200815318947405
PubMed Web of Science ®Google Scholar
NandakumarVSinghTKatiyarSMulti-targeted prevention and therapy of cancer by proanthocyanidinsCancer Lett2008269237838718457915
PubMed Web of Science ®Google Scholar
CostaSUtanACervellatiRSperoniEGuerraMCCatechins: natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1)Food Chem Toxicol200745101910191717548142
PubMed Web of Science ®Google Scholar
FridmanJLoweSControl of apoptosis by p53Oncogene200322569030904014663481
PubMed Web of Science ®Google Scholar
DyerMJMacFarlaneMCohenGMBarriers to effective TRAIL-targeted therapy of malignancyJ Clin Oncol200725284505450617906217
PubMed Web of Science ®Google Scholar
MahalingamDSzegezdiEKeaneMde JongSSamaliATRAIL receptor signaling and modulation: are we on the right TRAIL?Cancer Treat Rev200935328028819117685
PubMed Web of Science ®Google Scholar
AshkenaziADixitVMDeath receptors: signaling and modulationScience19982815381130513089721089
PubMed Web of Science ®Google Scholar
WileySRSchooleyKSmolakPJIdentification and characterization of a new member of the TNF family that induces apoptosisImmunity1995366736828777713
PubMed Web of Science ®Google Scholar
AggarwalBBSignalling pathways of the TNF superfamily: a double-edged swordNat Rev Immunol20033974575612949498
PubMed Web of Science ®Google Scholar
AshkenaziATargeting death and decoy receptors of the tumour-necrosis factor superfamilyNat Rev Cancer20022642043012189384
PubMed Web of Science ®Google Scholar
PeperzakVVeraarEAKellerAMXiaoYBorstJThe Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulationJ Immunol2010185116670667821048108
PubMed Web of Science ®Google Scholar
DenoeudJMoserMRole of CD27/CD70 pathway of activation in immunity and toleranceJ Leukoc Biol201189219520320699361
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date